Stocktoria
SI-BONE, Inc. SIBN
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2018-10-17
SI-BONE, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 79.6% | 79.0% | 78.8% | 85.2% | 88.4% |
| Operating margin | -11.1% | -21.1% | -33.8% | -56.0% | -57.3% |
| Net margin | -9.4% | -18.5% | -31.2% | -57.6% | -62.8% |
| FCF margin | -4.5% | -13.7% | -19.1% | -48.1% | -50.9% |
| Return on assets | -7.9% | -13.4% | -18.8% | -38.9% | -29.7% |
| Return on equity | -10.6% | -18.5% | -25.6% | -62.3% | -42.1% |
| Debt / equity | 0.20× | 0.21× | 0.21× | 0.36× | 0.26× |
| Current ratio | 8.55 | 7.66 | 9.01 | 6.50 | 10.41 |
| Revenue growth | 20.2% | 20.4% | 30.5% | 18.0% | 22.8% |
Source: SEC EDGAR filings · CIK 0001459839 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.